Abstract:Currently worldwide attention has focused on the derivation of human embryonic stem cells (hESCs) for future therapeutic medicine. However, the majority of existing hESCs are directly or indirectly exposed to non-human materials during their derivation and/or propagation, which greatly restrict their therapeutic potential. Besides the efforts to improve culture systems, the derivation procedure, especially blastocyst manipulation, needs to be optimized. We adopted a non-contact laser-assisted hatching system in combination with sequential culture process to obtain hatched blastocysts as materials for hESC derivation, and derived a hESC line ZJUhES-1 of a Chinese population without exposure to any non-human materials during blastocyst manipulation. ZJUhES-1 satisfies the criteria of pluripotent hESCs: typically morphological characteristics; the expression of alkaline phosphatase, human telomerase reverse transcriptase and multiple hESC-specific markers including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, OCT-4, Nanog, Rex-1, Sox-2, UTF-1, Connexins 43 and 45, TERF-1 and TERF-2, Glut-1, BCRP-1/ABCG-2, GDF3, LIN28, FGF4, Thy-1, Cripto1/TDGF1, AC133 as well as SMAD1/2/3/5; extended proliferative capacity; maintenance of a stable male karyotype after long-term cultivation; and robust multiple-lineage developmental potentials both in vivo and in vitro. Moreover, ZJUhES-1 has distinct identity revealed from DNA fingerprinting. Our xeno-free blastocyst manipulation procedure may promote the progression toward clinical-grade hESC derivation.

Correction: Corrigendum: Establishment and Characterization of Human Germline Stem Cell Line with Unlimited Proliferation Potentials and No Tumor Formation

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

Correction: Corrigendum: CRISPR/Cas9-mediated efficient and heritable targeted mutagenesis in tomato plants in the first and later generations

Correction: Corrigendum: Epigenomic Reprogramming of Adult Cardiomyocyte-Derived Cardiac Progenitor Cells

Correction: Corrigendum: ImmuSort, a Database on Gene Plasticity and Electronic Sorting for Immune Cells

Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Corrigendum to ‘Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs)’ [Genes Dis 8(6) (2021 Jan 28) 814-826]

Corrigendum: Inhibition of TGF-β/Smad3 Signaling Disrupts Cardiomyocyte Cell Cycle Progression and Epithelial–Mesenchymal Transition-Like Response During Ventricle Regeneration

Corrigendum to “development and Characterization of 5 Canine B-cell Lymphoma Cell Lines” [leuk. Res. 36(5) (2011) 601–606]

[Corrigendum] Upregulation of centromere protein M promotes tumorigenesis: A potential predictive target for cancer in humans

[Corrigendum] Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord

Correction: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Author Correction: Suppression of M 6 A Reader Ythdf2 Promotes Hematopoietic Stem Cell Expansion

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Human Embryonic Stem Cell Lines Derived from the Chinese Population

Corrigendum: Advances in understanding the regulation of pluripotency fate transition in embryonic stem cells

Correction: Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Establishment of Human Embryonic Stem Cell Line NJGLLhES1

Correction: Corrigendum: Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia